Uremic toxins: do we know enough to explain uremia?
- PMID: 18182802
- DOI: 10.1159/000110570
Uremic toxins: do we know enough to explain uremia?
Abstract
Background: The uremic syndrome is characterized by a complex clinical picture, whereby the function of multiple organ systems is affected by the retention of a host of solutes. Recent research of the last decade has helped to unravel multiple pathophysiologic mechanisms and to identify as yet unknown responsible compounds.
Methods: The literature was screened to appreciate which compounds play the most important pathophysiologic role.
Results: The picture that ensues is that the main role is played by molecules which are so-called 'difficult to remove by dialysis'. The knowledge of uremic toxicity is still far from complete and we need extra information about responsible compounds and mechanisms, eventually leading to a classification of the most important culprits, to allow the development of efficient removal strategies and of pharmacologic methods to counteract pathophysiologic mechanisms.
Conclusions: Uremic retention is a complex phenomenon and the most toxic compounds are difficult to remove by dialysis. Furthermore, our knowledge of the responsible pathways is still incomplete, and needs to be extended to develop new and more efficient treatment strategies.
(c) 2008 S. Karger AG, Basel.
Similar articles
-
From uremic toxin retention to removal by convection: do we know enough?Contrib Nephrol. 2008;161:125-131. doi: 10.1159/000130657. Contrib Nephrol. 2008. PMID: 18451668 Review.
-
A bench to bedside view of uremic toxins.J Am Soc Nephrol. 2008 May;19(5):863-70. doi: 10.1681/ASN.2007121377. Epub 2008 Feb 20. J Am Soc Nephrol. 2008. PMID: 18287557 Review.
-
Biochemical and clinical evidence for uremic toxicity.Artif Organs. 2004 Mar;28(3):248-53. doi: 10.1111/j.1525-1594.2004.47315.x. Artif Organs. 2004. PMID: 15046622 Review.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
What is uremia? Retention versus oxidation.Blood Purif. 2006;24(1):33-8. doi: 10.1159/000089434. Blood Purif. 2006. PMID: 16361838 Review.
Cited by
-
The membrane perspective of uraemic toxins: which ones should, or can, be removed?Clin Kidney J. 2021 Dec 27;14(Suppl 4):i17-i31. doi: 10.1093/ckj/sfab202. eCollection 2021 Dec. Clin Kidney J. 2021. PMID: 34987783 Free PMC article. Review.
-
Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.Curr Diab Rep. 2017 Mar;17(3):16. doi: 10.1007/s11892-017-0841-z. Curr Diab Rep. 2017. PMID: 28271466 Review.
-
Proteomic analisys of protein extraction during hemofiltration with on-line endogenous reinfusion (HFR) using different polysulphone membranes.J Mater Sci Mater Med. 2014 Dec;25(12):2691-8. doi: 10.1007/s10856-014-5290-5. Epub 2014 Jul 30. J Mater Sci Mater Med. 2014. PMID: 25074835 Clinical Trial.
-
Rhubarb Enema Attenuates Renal Tubulointerstitial Fibrosis in 5/6 Nephrectomized Rats by Alleviating Indoxyl Sulfate Overload.PLoS One. 2015 Dec 15;10(12):e0144726. doi: 10.1371/journal.pone.0144726. eCollection 2015. PLoS One. 2015. PMID: 26671452 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical